KPV reconstitution calculator
- Concentration
- 5 mg/mL
- Doses per vial
- 20
- Weeks (1 dose/wk)
- 20
10 units (0.1 mL) on a 1 mL U-100 syringe: 500 mcg from a 10 mg vial + 2 mL water (KPV).
Dosing table for a 10 mg vial
Syringe units (U-100) for each dose, by how much bacteriostatic water you add.
| Dose | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 100 mcg | 1 | 2 | 2.5 | 3 |
| 200 mcg | 2 | 4 | 5 | 6 |
| 250 mcg | 2.5 | 5 | 6.25 | 7.5 |
| 500 mcg | 5 | 10 | 12.5 | 15 |
| 750 mcg | 7.5 | 15 | 18.75 | 22.5 |
| 1000 mcg | 10 | 20 | 25 | 30 |
How the math works
Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.
500 mcg = 0.5 mg; 0.5 mg ÷ 5 mg/mL = 0.1 mL
0.1 mL × 100 = 10 units
How many units is 500 mcg of KPV?
With a 10 mg vial and 2 mL of bacteriostatic water, 500 mcg is 10 units (0.10 mL) on a U-100 syringe. With 1 mL of water it is 5 units. The answer always depends on how much water was added.
How much bacteriostatic water for a 10 mg KPV vial?
The water only sets the concentration; the amount of KPV in the vial stays the same. 2 mL makes 5 mg/mL, so 500 mcg is 10 units. 2.5 mL makes 4 mg/mL, so the same 500 mcg is 12.5 units. More water makes small doses easier to measure but needs more volume per injection.
How many 500 mcg doses are in a 10 mg vial?
10 mg is 10,000 mcg; 10,000 ÷ 500 = 20, so 20 full doses of 500 mcg. Any liquid lost in the needle and vial is not counted.
How to reconstitute KPV?
There is no label. A 10 mg vial in 2 mL is 5 mg/mL and a 20 mg vial in 2 mL is 10 mg/mL; the volume of water only sets the strength.
Calculated from vials mg 10, 20; water m L 2. Formula: 10/2 = 5 mg/mL; 20/2 = 10 mg/mL
How much bac water for KPV?
For a 5 mg vial, 1 mL gives 5 mg/mL, 2 mL gives 2.5 mg/mL and 5 mL gives 1 mg/mL; the strength sets mcg per unit as 50, 25 and 10.
Calculated from vial mg 5; water m L 1, 2, 5. Formula: 5/1 = 5; 5/2 = 2.5; 5/5 = 1 mg/mL; x 10 = 50, 25, 10 mcg per unit
Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for KPV in community discussions.
The few KPV amounts on record are rabbit milligrams and culture concentrations
In febrile rabbits the tripeptide reduced fever after central administration at 0.5-2.0 mg and after peripheral administration at 2-200 mg, as printed in the abstract; this was an animal study from the early literature.[3]
A keratinocyte cell study found that 50 μg/mL of KPV restored cell viability and reduced IL-1β secretion disrupted by PM10 exposure.[4]
Mouse colitis studies used 2 models of inflammatory bowel disease, DSS colitis and transfer colitis, but the cached abstracts give no mass per injection.[5]
Skin delivery
Skin-delivery work found KPV below the detection limit of 0.01 μg/mL after simple passive diffusion through human skin, and 4.4 μg/cm2/h when microneedles were used.[6]
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Effect of alpha-MSH 11-13 (lysine-proline-valine) on fever in the rabbit.Peptides · 1984PMID 6333677Accessed 2 Oct 2026
- 4Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.Tissue & cell · 2025PMID 40073467Accessed 2 Oct 2026
- 5Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
- 6Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.Journal of pharmaceutical sciences · 2017PMID 28343991Accessed 2 Oct 2026
Found an error? Report a correction.